Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daphne Stewart

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Current Opinion in Obstetrics & Gynecology|December 12, 2018
Antibody-drug conjugates for ovarian cancer: current clinical developmentDaphne Stewart, Mihaela Cristea
Seminars in Hematology|July 19, 2002
Towards safer thrombolytic therapyVictor J Marder, Daphne Stewart
Blood|February 18, 2009
Differentiation therapy of leukemia: 3 decades of developmentDaniel Nowak, Daphne Stewart, H Phillip Koeffler
Cancers|December 30, 2025
HER2-Low and HER2-Ultralow Metastatic Breast Cancer and Trastuzumab Deruxtecan: Common Clinical Questions and AnswersNusayba A Bagegni, Karthik V Giridhar, Daphne Stewart
Blood|November 26, 2002
Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhageDaphne Stewart, Mansze Kong, Valery Novokhatny, et al.
Stroke|March 15, 2008
Middle cerebral artery occlusion in the rabbit using selective angiography: application for assessment of thrombolysisReza Jahan, Daphne Stewart, Harry V Vinters, et al.
Cancer Research|October 2, 2024
Impact of Structural Racism and Social Determinants of Health on Disparities in Breast Cancer MortalityMary Falcone, Bodour Salhia, Chanita Hughes Halbert, et al.
Cancer Chemotherapy and Pharmacology|October 24, 2019
Characterization of infections and hypogammaglobulinemia treated with the combination of pertuzumab and trastuzumabJoanne E Mortimer, Laura Kruper, Jae Jung, et al.
Breast Cancer Research and Treatment|November 12, 2014
Skin/nail infections with the addition of pertuzumab to trastuzumab-based chemotherapyJoanne Mortimer, Jae Jung, Yuan Yuan, et al.
Cancer Research Communications|November 30, 2023
Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian CancerFerdynand J Kos, Paul Frankel, Mihaela Cristea, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Current Opinion in Obstetrics & Gynecology|December 12, 2018
Antibody-drug conjugates for ovarian cancer: current clinical developmentDaphne Stewart, Mihaela Cristea
Seminars in Hematology|July 19, 2002
Towards safer thrombolytic therapyVictor J Marder, Daphne Stewart
Blood|February 18, 2009
Differentiation therapy of leukemia: 3 decades of developmentDaniel Nowak, Daphne Stewart, H Phillip Koeffler
Cancers|December 30, 2025
HER2-Low and HER2-Ultralow Metastatic Breast Cancer and Trastuzumab Deruxtecan: Common Clinical Questions and AnswersNusayba A Bagegni, Karthik V Giridhar, Daphne Stewart
Blood|November 26, 2002
Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhageDaphne Stewart, Mansze Kong, Valery Novokhatny, et al.
Stroke|March 15, 2008
Middle cerebral artery occlusion in the rabbit using selective angiography: application for assessment of thrombolysisReza Jahan, Daphne Stewart, Harry V Vinters, et al.
Cancer Research|October 2, 2024
Impact of Structural Racism and Social Determinants of Health on Disparities in Breast Cancer MortalityMary Falcone, Bodour Salhia, Chanita Hughes Halbert, et al.
Cancer Chemotherapy and Pharmacology|October 24, 2019
Characterization of infections and hypogammaglobulinemia treated with the combination of pertuzumab and trastuzumabJoanne E Mortimer, Laura Kruper, Jae Jung, et al.
Breast Cancer Research and Treatment|November 12, 2014
Skin/nail infections with the addition of pertuzumab to trastuzumab-based chemotherapyJoanne Mortimer, Jae Jung, Yuan Yuan, et al.
Cancer Research Communications|November 30, 2023
Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian CancerFerdynand J Kos, Paul Frankel, Mihaela Cristea, et al.
Pageof 3